Management of Peritonsillar Abscess

Antibiotic Selection

• The American Academy of Pediatrics and other guideline societies recommend that children with peritonsillar abscess and a history of asthma should receive aggressive initial management with antibiotics, such as clindamycin, due to the increased risk of complications 1, 2, 3
• Amoxicillin-clavulanate can be considered as an alternative regimen, particularly for outpatient management, with a dosage of 80 mg/kg/day in three doses, not exceeding 3 g/day, although it may not provide optimal anaerobic coverage 1, 2, 3

Surgical Considerations

• The American Academy of Otolaryngology-Head and Neck Surgery recommends considering tonsillectomy in children with a history of more than one peritonsillar abscess, even if they don't meet standard frequency criteria for recurrent throat infections 4, 5, 6
• Perioperative antibiotics should NOT be prescribed if the patient proceeds to tonsillectomy, as this is strongly recommended against by current guidelines from the American Academy of Otolaryngology-Head and Neck Surgery 4, 5, 6

Route and Duration

• The duration of antibiotic treatment is typically 7-10 days, although this should be adjusted based on clinical response, as recommended by the Infectious Diseases Society of America and other guideline societies 1, 2, 3

Treatment of Peritonsillar Abscess

Antibiotic Therapy

• First-line antibiotics should be effective against Group A streptococcus, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery, with a strength of evidence based on clinical guidelines 7

Indications for Tonsillectomy

• The American Academy of Otolaryngology-Head and Neck Surgery guidelines suggest that tonsillectomy should be considered in patients with a history of peritonsillar abscess, with a modifying factor being a history of more than one peritonsillar abscess 8
• A history of more than one peritonsillar abscess is a factor that may favor tonsillectomy, even in patients who do not meet standard frequency criteria for recurrent throat infections, according to clinical guidelines 9

Antibiotic Choice for Peritonsillar Abscess

Penicillin Allergy Considerations

• For patients with severe penicillin hypersensitivity, clindamycin remains the drug of choice as it is not cross-reactive and provides the necessary anaerobic coverage 10

Antibiotic Therapy for Peritonsillar Abscess

First-Line Antibiotic Selection and Penicillin Allergy Management

• For patients with non-severe penicillin reactions, the American Academy of Pediatrics recommends considering cephalosporins like cefdinir, cefuroxime, or cefpodoxime, as cross-reactivity rates are lower than historically reported (likely <10%) 11, 12

Parenteral Antibiotic Regimen for Peritonsillar Abscess

Initial Antibiotic Selection

• The Infectious Diseases Society of America recommends intravenous penicillin dosing of 2-4 million units every 4-6 hours for hospitalized patients requiring parenteral therapy after drainage 13
• Clindamycin 600-900 mg every 6-8 hours IV is the preferred alternative for patients with severe penicillin hypersensitivity or when broader anaerobic coverage is needed, with a dosing of 10-13 mg/kg/dose every 8 hours IV for pediatric patients 13

Critical Management Principles

• The American College of Physicians recommends treatment extension if infection has not improved within the initial 3-5 days of antibiotics after adequate source control 13

Special Populations

• The American Academy of Pediatrics recommends penicillin dosing of 100,000 units/kg/day in divided doses for pediatric patients 13

Antibiotic Treatment for Peritonsillar Abscess

Common Pitfalls to Avoid

• The World Journal of Emergency Surgery recommends avoiding the use of fluoroquinolones as monotherapy due to their lack of adequate coverage for Group A streptococcus 14

Antibiotic Resistance and Clinical Documentation in Peritonsillar Abscess Management

Antibiotic Resistance

• Azithromycin and trimethoprim‑sulfamethoxazole should be avoided as monotherapy for peritonsillar abscess because surveillance studies have shown high resistance rates of Streptococcus pneumoniae and Haemophilus influenzae to these agents. 15, 16

Clinical Documentation

• Systematic documentation of each peritonsillar‑abscess episode is recommended to inform future decisions about interval tonsillectomy and to support optimal patient care pathways. 17